Maize-based specialty products manufacturing and supply for food, pharma, and other industries.
Annual revenue $60.1M Latest available
Total funding - Funding intelligence
Employees 349 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Paramesu Biotech

Paramesu Biotech is a company based in India. The company has 349 employees as of April 08, 2024. Paramesu Biotech offers products and services including Maize Starches and Maize Derivatives.

  • Headquarter India
  • Employees 349 as on 08 Apr, 2024
  • Sectors
    Agriculture
    Chemicals & Materials
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Paramesu Biotech Limited
  • Jurisdiction Devarapalli, Andhra Pradesh, India
Operational Areas
Agriculture → Agricultural Technology & Innovation Unlock Sub-Sector Unlock Segment
Chemicals & Materials → Polymers, Plastics & Petrochemicals Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $60.08 M (USD)
    87.58
    as on Mar 31, 2022
  • Net Profit
    $4.11 M (USD)
    278.71
    as on Mar 31, 2022
  • EBITDA
    $7.12 M (USD)
    134.62
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    349

    as on Apr 08, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Paramesu Biotech

Paramesu Biotech offers a comprehensive portfolio of products and services, including Maize Starches and Maize Derivatives.

Product name locked
Category locked
Primary

Maize starches are produced for use in food and other industries, ensuring optimal performance and reliability through established manufacturing processes

Product name locked
Category locked
Locked

Maize derivatives are supplied for sectors like pharmaceutical and paper, meeting diverse needs with precision and adherence to quality standards

Funding Insights of Paramesu Biotech

Premium access

Detailed funding history for Paramesu Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Paramesu Biotech

Investments
Premium access

Investment portfolio details for Paramesu Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Paramesu Biotech

Premium access

Detailed financials for Paramesu Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Paramesu Biotech Comparisons

Paramesu Biotech Primary company
Description
Maize-based specialty products manufacturing and supply for ...
Location
India
Founded Year
-
Annual Revenue
$60.08 M (USD)
Net Profit
$4.11 M (USD)
EBITDA
$7.12 M (USD)
Employees
349
As of 2024
Premium access

Peer comparison for Paramesu Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Paramesu Biotech

Premium access

Detailed competitors of Paramesu Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Paramesu Biotech

Premium access

Complete news archive for Paramesu Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paramesu Biotech

Paramesu Biotech is headquartered in India.

As of Apr 08, 2024, the latest employee count at Paramesu Biotech is 349.

Annual revenue of Paramesu Biotech is $60.08M as on Mar 31, 2022.

Paramesu Biotech Limited, established in 2011, is identified as a major manufacturer of maize-based specialty products that are supplied to various industries including food, pharmaceutical, and paper. An international presence is maintained through exports to multiple countries, with a focus on quality and sustainability being upheld via certifications like FSSAI and ISO. The companys operations are recognized for adhering to high standards, as evidenced by the Great Place to Work certification. Products such as starches and derivatives are tailored to meet industry needs, ensuring reliability and performance in global markets.

Paramesu Biotech offers Maize Starches and Maize Derivatives.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available